These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1899305)

  • 21. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of natural killer cells in mediating graft-versus-host disease following small bowel transplantation in a rat model.
    Fändrich F; Exner B; Papachrysanthou A; Jahnke T; Chambers WH; Zavazava N
    Transplant Proc; 1996 Oct; 28(5):2465-6. PubMed ID: 8907904
    [No Abstract]   [Full Text] [Related]  

  • 23. The existence of graft-versus-host disease in long-term surviving fully allogeneic rat small bowel transplant recipients.
    Diflo T; Maki T; Monaco AP
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2875-6. PubMed ID: 2784916
    [No Abstract]   [Full Text] [Related]  

  • 24. Allograft ultraviolet-B irradiation in rat small intestinal transplantation.
    Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1624-5. PubMed ID: 8030062
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunosuppression by combined liver transplantation in the rat mechanisms of graft acceptance and regulation of graft-vs-host disease.
    Kobayashi E; Kamada N; Enosawa S; Toyama N; Lord R; Stamatiou S; Delriviere L; Miyata M
    Transplant Proc; 1994 Jun; 26(3):1575-7. PubMed ID: 8030042
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histology of host and graft lymphoid tissue in a chronic orthotopic bowel allograft model in the rat.
    Masaki Y; Shimazu R; Grogan JB; Subramony C; Raju S
    Transplant Proc; 1991 Feb; 23(1 Pt 1):672-4. PubMed ID: 1990643
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulation of donor T cells in the tolerant rats to graft-versus-host disease by FTY720 following small bowel transplantation.
    Song J; Ito T; Matsuda C; Tanemura M; Nishida T; Nozawa M; Sawa Y
    Transplant Proc; 2006 Dec; 38(10):3181-3. PubMed ID: 17175216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of graft-vs-host-related disease by host-specific natural killer cell activity following semiallogeneic small bowel transplantation in the rat.
    Fändrich F; Schröder J; Jahnke T; Dresske B; Chambers WH; Zavazava N
    Transplant Proc; 1996 Dec; 28(6):3267-8. PubMed ID: 8962268
    [No Abstract]   [Full Text] [Related]  

  • 30. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
    Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
    [No Abstract]   [Full Text] [Related]  

  • 31. Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation.
    Murase N; Demetris AJ; Woo J; Furuya T; Nalesnik M; Tanabe M; Todo S; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3246-7. PubMed ID: 1721424
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo immunosuppressive effects of monoclonal antibodies specific for CD3+, CD4+, CD8+, and MHC class II positive cells.
    Stevens HP; Roche N; Hovius SE; Jonker M
    Transplant Proc; 1990 Aug; 22(4):1783-4. PubMed ID: 2143861
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-CD4 IgG2a monoclonal antibody treatment prevents the expansion of T cells in the spleen during murine graft-vs-host disease.
    Noort WA; Benner R; Savelkoul HF
    Transplant Proc; 1995 Feb; 27(1):384-6. PubMed ID: 7879030
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental study of combined treatment with tacrolimus and donor splenocytes via the portal vein in small bowel transplantation.
    Miyauchi T; Ishikawa M; Tashiro S; Hisaeda H; Himeno K
    J Med Invest; 2001 Aug; 48(3-4):157-65. PubMed ID: 11694955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of T-cell subsets in rat liver allograft rejection.
    Yokoi Y; Sumimoto R; Yamaguchi A; Baba S; Nakamura S; Kimura H
    Transplant Proc; 1993 Apr; 25(2):1994-6. PubMed ID: 8470255
    [No Abstract]   [Full Text] [Related]  

  • 36. Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporine.
    Brunson ME; Tchervenkov JI; Alexander JW; Cofer BR
    Transplant Proc; 1991 Feb; 23(1 Pt 1):307-8. PubMed ID: 1990538
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results.
    Soiffer RJ; Ritz J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S7-10. PubMed ID: 8124262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-graft and anti-host antibody responses following small bowel transplantation in the rat.
    Bowles MJ; Wood RF; Pockley AG
    Transplant Proc; 1996 Oct; 28(5):2486. PubMed ID: 8907916
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
    Hamano K; Morris PJ; Wood KJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
    [No Abstract]   [Full Text] [Related]  

  • 40. Amelioration of graft-versus-host disease following bowel transplantation with recipient specific leukocyte transfusion.
    Xiao F; Foster PF; Sankary HN; Kociss K; Williams JW
    Transplant Proc; 1992 Jun; 24(3):1192-3. PubMed ID: 1604582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.